Literature DB >> 26621683

Short-Wavelength Automated Perimetry Parameters at Baseline and Following Remission in Patients With Birdshot Retinochoroidopathy.

Arash Maleki1, Robert T Swan1, Sukhum Silpa-Archa2, Janine M Preble1, Yuchen He3, C Stephen Foster4.   

Abstract

PURPOSE: To identify changes in short-wavelength automated perimetry patterns and parameters between the active and inactive states.
DESIGN: Retrospective cohort study with age-matched, normal controls.
METHODS: setting: Private tertiary referral center. STUDY POPULATION: Seventy-five eyes of 38 patients with active birdshot retinochoroidopathy and 37 eyes of 37 historical normal controls. INTERVENTION: Thirty-seven patients received immunomodulatory therapy. A fluocinolone acetonide intravitreal implant (Retisert) was implanted in both eyes of 1 patient as an initial treatment. MAIN OUTCOME MEASURES: Changes in short-wavelength automated perimetry total deviation scores, pattern deviation scores, mean deviation, and pattern standard deviation in the active phase and the remission state.
RESULTS: Mean deviation (P = .006), pattern standard deviation (P = .001), total deviation score (P = .002), and pattern deviation score (P = .007) were significantly different from the active phase to the remission state. The length of time required to achieve remission did not significantly affect the changes in mean deviation (regression coefficient = 0.01; P = .92), pattern standard deviation (regression coefficient = 0.01; P = .87), total deviation score (regression coefficient = -0.1; P = .32), or pattern deviation score (regression coefficient = 0.1; P = .36) from the active phase to the remission state.
CONCLUSION: There was significant improvement in total deviation score, pattern deviation score, mean deviation, and pattern standard deviation on short-wavelength automated perimetry as patients achieved remission. Short-wavelength automated perimetry appears to be a useful and complementary modality in monitoring disease activity in birdshot retinochoroidopathy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26621683     DOI: 10.1016/j.ajo.2015.11.024

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Relationship between changes in retinal nerve fiber layer thickness measured by SD-OCT and changes in visual field parameters in birdshot chorioretinopathy.

Authors:  Aurélia Gave; Lucile Cotella; José Labarere; Florent Aptel; Christophe Chiquet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-29       Impact factor: 3.117

2.  Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy.

Authors:  Arash Maleki; Neerav Lamba; Lina Ma; Stacey Lee; Alexander Schmidt; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2017-02-17

3.  Short wavelength automated perimetry and standard automated perimetry in central serous chorioretinopathy.

Authors:  Han Peng Zhou; Ryo Asaoka; Tatsuya Inoue; Shotaro Asano; Hiroshi Murata; Takumi Hara; So Makino; Kazuaki Kadonosono; Ryo Obata
Journal:  Sci Rep       Date:  2020-10-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.